GeoVax Labs, Inc. Announces Securities Purchase Agreement with Institutional Investor
GeoVax Labs, Inc. announces a securities purchase agreement with an institutional investor, securing funding for the development of immunotherapies and vaccines against cancer and infectious diseases.
This news is important as it highlights GeoVax Labs, Inc.'s efforts to secure funding for the development of immunotherapies, vaccines against cancer, and infectious diseases. It demonstrates the company's commitment to advancing its clinical programs and contributing to the fight against global health threats.
